The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.
August 22nd 2025
The MyLab A50 and MyLab A70 ultrasound platforms reportedly enable a variety of detailed and multiparametric evaluations, including assessments for liver elastography and strain analysis echocardiography.
Breast ultrasound adjusts to get past false positives
January 10th 2008The massive American College of Radiology Imaging Network 6666 trial shows that adding ultrasound to the initial breast screening protocol for high-risk women could help detect 30% more cancers, but at the questionable cost of many more needless biopsies of benign lesions.
Lack of national diagnosis, care plan spurs call for action
January 10th 2008Prostate cancer imaging experts sent out a clear message in 2007: Prostate cancer in the U.S. has become an unrecognized patient care crisis that needs tackling. The good news is these experts agree that advanced imaging technologies could help in early detection and minimally invasive treatment. The lack of a cohesive national strategy is worrisome, however, and they want to see the adoption of a broad initiative for diagnosing and treating prostate cancer similar to that for breast cancer.
MR elastography proves edge in liver fibrosis staging
January 10th 2008Researchers in Belgium have found that MR elastography is more accurate than a blood test commonly used in the noninvasive staging of liver fibrosis. The study adds weight to clinical literature that suggests MR elastography could replace biopsy.
FDA warning flummoxes ultrasound contrast trial
January 10th 2008Plans for a clinical trial designed to overcome long-standing regulatory obstacles to the general clinical use of ultrasound contrast media in the U.S. have been knocked off track by an FDA-mandated black box safety warning for two microbubble agents approved for echocardiography.
Fractures and liver lesions top list of residents' ER misses
January 10th 2008Researchers used a customized search engine to quickly find that most discordant resident versus attending physician preliminary reports involved fractures, liver/kidney lesions, pulmonary nodules, and gastrointestinal wall thickening.
Breast MR imaging aids high-risk women
January 10th 2008A large prospective screening trial from the University of Pennsylvania compared screen-film mammography, digital mammography, whole-breast ultrasound, and contrast-enhanced MRI in a population of 569 asymptomatic women. In this single-center trial, funded by the National Cancer Institute, the definition of high risk included women with a 25% lifetime risk based on genetic testing or Gail or Claus models and those with a history of cancer in the contralateral breast.
‘Care areas’ characterize GE approach to ultrasound
January 3rd 2008GE Healthcare this week introduced two tailored, highly portable ultrasound systems, one for emergency medicine, the other for anesthesia. Although these systems are narrowly focused in the clinical sense, they reflect a multifaceted corporate approach to ultrasound that leverages different technologies to achieve specific goals.
New GE units address rising demand for hand-carried ultrasound
January 3rd 2008The worldwide market for compact ultrasound scanners is expected to grow 36% in 2007, according to Harvey Klein, ultrasound industry analyst and president of Klein Biomedical Consultants. GE reports that global revenue from the sale of compact ultrasound systems grew to $175 million in the third quarter, a 65% gain over the year-earlier period.
Ultrasound provides noninvasive assessment of vocal fold lesions
December 26th 2007Laryngeal ultrasound can provide useful diagnostic information about benign lesions of the vocal folds. Unlike other assessment methods, it is noninvasive and inexpensive and requires no anesthesia or radiation.
Corporate and academic R&D target stroke with ultrasound
December 20th 2007Philips is working with contrast agent developer ImaRx to find information that might turn diagnostic ultrasound scanners into weapons against acute ischemic stroke, the companies announced early this month. Research at Oregon Health & Science University may complement Philips’ collaboration, providing information to use against a disease with annual medical costs approaching $63 billion.
Corporate and academic R&D target stroke with ultrasound
December 20th 2007Philips is working with contrast agent developer ImaRx to find information that might turn diagnostic ultrasound scanners into weapons against acute ischemic stroke, the companies announced early this month. Research at Oregon Health & Science University may complement Philips’ collaboration, providing information to use against a disease with annual medical costs approaching $63 billion.
Bedside ultrasound shows placement of pediatric endotracheal tubes
December 17th 2007Bedside ultrasound quickly and accurately verifies the placement of endotracheal tubes in pediatric patients, even when the standard tests give false-negative or equivocal results, according to a recent study.
Contrast-enhanced ultrasound shows new marker for atherosclerosis
December 10th 2007Contrast-enhanced ultrasound of the carotid artery can identify the presence and degree of vascularization in atherosclerotic plaque, providing a noninvasive way to measure the existence and degree of atherosclerosis, according to a recent study.
Report from RSNA: Radiologists, sonologists say, ‘Don’t pull plug on contrast ultrasound’
December 4th 2007An overwhelming majority of the audience at an RSNA special focus session voted in favor of keeping up the efforts to get FDA approval for the use of contrast ultrasound for general radiology applications.
Ultrasound-guided injections control recurrent papillary thyroid carcinoma
December 3rd 2007Ultrasound-guided percutaneous ethanol injections hold up as a treatment for controlling neck recurrence of papillary thyroid carcinoma. They could be effective for patients who are poor candidates for surgery.
Breast ultrasound boosts detection, benign biopsies
December 1st 2007Breast ultrasound significantly increases detection of cancers in high-risk women but takes a big toll in the rate of benign biopsies, according to the initial results of a screening trial sponsored by the American College of Radiology Imaging Network and the Avon Foundation.